Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
MELBOURNE, Australia, Jan. 12, 2016 (GLOBE NEWSWIRE) -- Australian microbiome biopharmaceutical company Immuron Limited (ASX:IMC) (OTCQB:IMROY) today announced that IMM-529, a first-in-class oral...
-
MELBOURNE, Australia, Nov. 18, 2015 (GLOBE NEWSWIRE) -- Australian biopharmaceutical Company Immuron Limited (ASX:IMC) (OTCQB:IMROY) is pleased to announce that the Company’s Phase IIb, the...
-
MELBOURNE, Australia, Nov. 12, 2015 (GLOBE NEWSWIRE) -- Immuron Limited (ASX:IMC) (OTCQB:IMROY) is pleased to announce that the Company has executed a non-exclusive distribution agreement with...
-
MELBOURNE, Australia, Nov. 11, 2015 (GLOBE NEWSWIRE) -- Immuron Limited (ASX:IMC) (OTCQB:IMROY) is pleased to announce that the company has executed a partnership agreement with TravelCare...
-
MELBOURNE, Australia, Nov. 10, 2015 (GLOBE NEWSWIRE) -- Immuron Limited (ASX:IMC) (OTCQB:IMROY) is pleased to announce that the Company has executed a partnership with US travel clinic leader...
-
MELBOURNE, Australia, Nov. 09, 2015 (GLOBE NEWSWIRE) -- Immuron Limited (ASX:IMC) (OTCQB:IMROY) and One Way Liver S.L. (OWL Metabolomics), a leader in the field of metabolomics and liver diseases...